These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12532427)

  • 1. Dynamic T1-weighted monitoring of vascularization in human carcinoma heterotransplants by magnetic resonance imaging.
    Kiessling F; Heilmann M; Vosseler S; Lichy M; Krix M; Fink C; Kiessling I; Steinbauer H; Schad L; Fusenig NE; Delorme S
    Int J Cancer; 2003 Mar; 104(1):113-20. PubMed ID: 12532427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101.
    Kiessling F; Farhan N; Lichy MP; Vosseler S; Heilmann M; Krix M; Bohlen P; Miller DW; Mueller MM; Semmler W; Fusenig NE; Delorme S
    Neoplasia; 2004; 6(3):213-23. PubMed ID: 15153333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of vascular remodeling under antiangiogenic therapy using DCE-MRI and vessel size imaging.
    Zwick S; Strecker R; Kiselev V; Gall P; Huppert J; Palmowski M; Lederle W; Woenne EC; Hengerer A; Taupitz M; Semmler W; Kiessling F
    J Magn Reson Imaging; 2009 May; 29(5):1125-33. PubMed ID: 19388117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing dynamic parameters of tumor vascularization in nude mice revealed by magnetic resonance imaging and contrast-enhanced intermittent power Doppler sonography.
    Kiessling F; Krix M; Heilmann M; Vosseler S; Lichy M; Fink C; Farhan N; Kleinschmidt K; Schad L; Fusenig NE; Delorme S
    Invest Radiol; 2003 Aug; 38(8):516-24. PubMed ID: 12874518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive noninvasive monitoring of tumor perfusion during antiangiogenic therapy by intermittent bolus-contrast power Doppler sonography.
    Krix M; Kiessling F; Vosseler S; Farhan N; Mueller MM; Bohlen P; Fusenig NE; Delorme S
    Cancer Res; 2003 Dec; 63(23):8264-70. PubMed ID: 14678984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging of tumor necrosis.
    Egeland TA; Gaustad JV; Galappathi K; Rofstad EK
    Acta Oncol; 2011 Apr; 50(3):427-34. PubMed ID: 20950229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
    Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
    Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts.
    Huuse EM; Moestue SA; Lindholm EM; Bathen TF; Nalwoga H; Krüger K; Bofin A; Maelandsmo GM; Akslen LA; Engebraaten O; Gribbestad IS
    J Magn Reson Imaging; 2012 May; 35(5):1098-107. PubMed ID: 22170753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of prostate carcinomas with T1-weighted dynamic contrast-enhanced MRI. Value of two-compartment model].
    Kiessling F; Lichy M; Grobholz R; Farhan N; Heilmann M; Michel MS; Trojan L; Werner A; Rabe J; Delorme S; Kauczor HU; Schlemmer HP
    Radiologe; 2003 Jun; 43(6):474-80. PubMed ID: 12827262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
    Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
    Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis and fibroblast proliferation precede formation of recurrent tumors after radiation therapy in nude mice.
    Hast J; Schiffer IB; Neugebauer B; Teichman E; Schreiber W; Brieger J; Kim DW; Gebhard S; Born CJ; Strugala M; Sagemüller J; Brenner W; Mann WJ; Oesch F; Thelen M; Hengstler JG
    Anticancer Res; 2002; 22(2A):677-88. PubMed ID: 12014637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis.
    Kiessling F; Greschus S; Lichy MP; Bock M; Fink C; Vosseler S; Moll J; Mueller MM; Fusenig NE; Traupe H; Semmler W
    Nat Med; 2004 Oct; 10(10):1133-8. PubMed ID: 15361864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of tumors: a preclinical study of cervical carcinoma and melanoma xenografts.
    Øvrebø KM; Ellingsen C; Hompland T; Rofstad EK
    Acta Oncol; 2013 Apr; 52(3):604-11. PubMed ID: 22671573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative dynamic contrast-enhanced MRI for the assessment of mandibular invasion by squamous cell carcinoma.
    Van Cann EM; Rijpkema M; Heerschap A; van der Bilt A; Koole R; Stoelinga PJ
    Oral Oncol; 2008 Dec; 44(12):1147-54. PubMed ID: 18485797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer.
    Preda A; Novikov V; Möglich M; Turetschek K; Shames DM; Brasch RC; Cavagna FM; Roberts TP
    J Magn Reson Imaging; 2004 Nov; 20(5):865-73. PubMed ID: 15503324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants.
    Vosseler S; Mirancea N; Bohlen P; Mueller MM; Fusenig NE
    Cancer Res; 2005 Feb; 65(4):1294-305. PubMed ID: 15735015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gadolinium-loaded nanoparticle as a novel molecular imaging contrast agent for magnetic resonance imaging].
    Liu LZ; Guo GJ; Zeng MS; Lü YC; Liu XW; Cui CY; Wu PH; Li L
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):240-3. PubMed ID: 17425867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping.
    Braren R; Curcic J; Remmele S; Altomonte J; Ebert O; Rummeny EJ; Steingoetter A
    Invest Radiol; 2011 Oct; 46(10):624-31. PubMed ID: 21577121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.